603 related articles for article (PubMed ID: 22168961)
1. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
4. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.
Gagnon P; Bussières JS; Ribeiro F; Gagnon SL; Saey D; Gagné N; Provencher S; Maltais F
Am J Respir Crit Care Med; 2012 Oct; 186(7):606-15. PubMed ID: 22822019
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
6. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease.
Mainguy V; Girard D; Maltais F; Saey D; Milot J; Sénéchal M; Poirier P; Provencher S
Am J Cardiol; 2012 Jul; 110(2):258-63. PubMed ID: 22497677
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
8. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
9. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
Beeh KM; Wagner F; Khindri S; Drollmann AF
COPD; 2011 Oct; 8(5):340-5. PubMed ID: 21793716
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
11. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
[TBL] [Abstract][Full Text] [Related]
12. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
[TBL] [Abstract][Full Text] [Related]
13. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726
[TBL] [Abstract][Full Text] [Related]
14. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
15. Walking exercise response to bronchodilation in mild COPD: a randomized trial.
Gagnon P; Saey D; Provencher S; Milot J; Bourbeau J; Tan WC; Martel S; Maltais F
Respir Med; 2012 Dec; 106(12):1695-705. PubMed ID: 22999808
[TBL] [Abstract][Full Text] [Related]
16. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
[TBL] [Abstract][Full Text] [Related]
17. Does nebulized fentanyl relieve dyspnea during exercise in healthy man?
Kotrach HG; Bourbeau J; Jensen D
J Appl Physiol (1985); 2015 Jun; 118(11):1406-14. PubMed ID: 26031762
[TBL] [Abstract][Full Text] [Related]
18. Effect of combination treatment on lung volumes and exercise endurance time in COPD.
Magnussen H; Paggiaro P; Schmidt H; Kesten S; Metzdorf N; Maltais F
Respir Med; 2012 Oct; 106(10):1413-20. PubMed ID: 22749044
[TBL] [Abstract][Full Text] [Related]
19. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
Peters MM; Webb KA; O'Donnell DE
Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
[TBL] [Abstract][Full Text] [Related]
20. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.
Palange P; Valli G; Onorati P; Antonucci R; Paoletti P; Rosato A; Manfredi F; Serra P
J Appl Physiol (1985); 2004 Nov; 97(5):1637-42. PubMed ID: 15234959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
